Zim Laboratories Ltd - 541400 - Compliances-Reg.24(A)-Annual Secretarial Compliance
In terms of SEBI Circular No. CIR/CFD/CMD1/27/2019 dated February 8, 2019, please find enclosed herewith an Annual Secretarial Compliance Report for the financial year ended March 31, 2021 issued by Ms. Roshni Jethani, Practicing Company Secretary. We request you to kindly take the same on your record. Zim Laboratories Ltd - 541400 - Closure of Trading Window
This is to inform you that pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, BSE Circular No. LIST/COMP/2019-20 dt. 02nd April, 2019, and Company's Code of Conduct to Regulate, Monitor and Report Trading by Insider's, the trading window for dealing with securities of the Company will remain closed from Thursday the 01st July, 2021, for 'Designated Persons', including Promoters/Directors/Key Managerial Personnel/Designated employees of the company and their immediate relatives. The Trading Window shall open after 48 hours of declaration of financial results of the company for the quarter ended 30th June, 2021. Kindly take the same on record. Zim Laboratories Ltd - 541400 - Announcement under Regulation 30 (LODR)-Resignation of Director
Pursuant to Regulation 30 read with Schedule III Part A Clause 7 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that Mr. Riazahmed Kamal (DIN: 00023562) has been a Director on the Board of the Company since the year 1998 and was reappointed for a term of five years from 26.12.2017 to 30.09.2022 has submitted his resignation to the Board due to health and personal issues, which is effective from 01.07.2021. Kindly take the intimation on record. Zim Laboratories Ltd - 541400 - Disclosure Under Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
In compliance with Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed is the disclosure of Related Party Transactions on a consolidated basis for the half year ended March 31, 2021. Zim Laboratories Ltd - 541400 - Reply To The Clarification Sought On Price Movement Of The Shares Of The Company
With reference to the clarification sought on the movement of share price of the company, please find enclosed clarification for the same. Zim Laboratories Ltd - 541400 - Clarification sought from Zim Laboratories Ltd
The Exchange has sought clarification from Zim Laboratories Ltd on June 24, 2021 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited. Zim Laboratories Ltd - 541400 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for AA Development Capital India Fund 1 LLC Zim Laboratories Ltd - 541400 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Elizabeth Mathew Zim Laboratories Ltd - 541400 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to the requests received from shareholder, the Company has issued Duplicate Share Certificates in place of Share Certificates lost/ misplaced etc. by the said shareholders. Zim Laboratories Ltd - 541400 - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015 - Corporate Presentation - June 2021
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, kindly find enclosed Corporate Presentation - June 2021.